Executive Order 14017 100 Days Review
The findings of the initial set of reviews of the supply chains of four critical products: semiconductor manufacturing and advanced packaging; large capacity batteries; critical minerals and materials and pharmaceuticals and active pharmaceutical ingredients (APIs).